https://www.taxtmi.com/news?id=73267 India's pharmaceutical sector is being positioned as a driver of affordable healthcare, global supply reliability and innovation-led growth, with emphasis on quality standards, manufacturing capability and wider access to medicines. Policy and industry priorities highlighted include expansion of pharmaceutical exports, market diversification, regulatory excellence and stronger international cooperation. The communication also announces iPHEX 2026 and the Global Drug Regulatory Conclave 2026 as platforms for showcasing Indian pharmaceutical capabilities and for engagement among regulators, policymakers, industry leaders and foreign missions. en-us Wed, 10 Jun 2026 10:33:22 +0530 Wed, 10 Jun 2026 10:33:21 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=73267 India's pharmaceutical sector is being positioned as a driver of affordable healthcare, global supply reliability and innovation-led growth, with emphasis on quality standards, manufacturing capability and wider access to medicines. Policy and industry priorities highlighted include expansion of pharmaceutical exports, market diversification, regulatory excellence and stronger international cooperation. The communication also announces iPHEX 2026 and the Global Drug Regulatory Conclave 2026 as platforms for showcasing Indian pharmaceutical capabilities and for engagement among regulators, policymakers, industry leaders and foreign missions. News - Wed, 10 Jun 2026 10:33:22 +0530 https://www.taxtmi.com/news?id=73267